87 related articles for article (PubMed ID: 23252995)
21. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.
Semenova VA; Schiffer J; Steward-Clark E; Soroka S; Schmidt DS; Brawner MM; Lyde F; Thompson R; Brown N; Foster L; Fox S; Patel N; Freeman AE; Quinn CP
J Immunol Methods; 2012 Feb; 376(1-2):97-107. PubMed ID: 22197974
[TBL] [Abstract][Full Text] [Related]
22. Quantitative assessment of anthrax vaccine immunogenicity using the dried blood spot matrix.
Schiffer JM; Maniatis P; Garza I; Steward-Clark E; Korman LT; Pittman PR; Mei JV; Quinn CP
Biologicals; 2013 Mar; 41(2):98-103. PubMed ID: 23266055
[TBL] [Abstract][Full Text] [Related]
23. Short report: Serodiagnosis of plague in humans and rats using a rapid test.
Thullier P; Guglielmo V; Rajerison M; Chanteau S
Am J Trop Med Hyg; 2003 Oct; 69(4):450-1. PubMed ID: 14640508
[TBL] [Abstract][Full Text] [Related]
24. Validation of high throughput screening of human sera for detection of anti-PA IgG by Enzyme-Linked Immunosorbent Assay (ELISA) as an emergency response to an anthrax incident.
Semenova VA; Steward-Clark E; Maniatis P; Epperson M; Sabnis A; Schiffer J
Biologicals; 2017 Jan; 45():61-68. PubMed ID: 27814939
[TBL] [Abstract][Full Text] [Related]
25. Development and application of a Bacillus anthracis protective antigen domain-1 in-house ELISA for the detection of anti-protective antigen antibodies in cattle in Zambia.
Simbotwe M; Fujikura D; Ohnuma M; Omori R; Furuta Y; Muuka GM; Hang'ombe BM; Higashi H
PLoS One; 2018; 13(10):e0205986. PubMed ID: 30335853
[TBL] [Abstract][Full Text] [Related]
26. Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax.
Boyer AE; Quinn CP; Beesley CA; Gallegos-Candela M; Marston CK; Cronin LX; Lins RC; Stoddard RA; Li H; Schiffer J; Hossain MJ; Chakraborty A; Rahman M; Luby SP; Shieh WJ; Zaki S; Barr JR; Hoffmaster AR
J Infect Dis; 2011 Nov; 204(9):1321-7. PubMed ID: 21908727
[TBL] [Abstract][Full Text] [Related]
27. Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines.
Parreiras PM; Sirota LA; Wagner LD; Menzies SL; Arciniega JL
Vaccine; 2009 Jul; 27(33):4537-42. PubMed ID: 19501205
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of serologic tests for diagnosis of anthrax after an outbreak of cutaneous anthrax in Paraguay.
Harrison LH; Ezzell JW; Abshire TG; Kidd S; Kaufmann AF
J Infect Dis; 1989 Oct; 160(4):706-10. PubMed ID: 2507648
[TBL] [Abstract][Full Text] [Related]
29. [Tuberculosis serodiagnosis, ELISA (enzyme-linked immunosorbent assay) and different mycobacterial antigens].
Saçilik SC
Mikrobiyol Bul; 1990 Jul; 24(3):198-204. PubMed ID: 2126594
[TBL] [Abstract][Full Text] [Related]
30. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
31. A human antibody against anthrax protective antigen protects rabbits from lethal infection with aerosolized spores.
Wild MA; Kumor K; Nolan MJ; Lockman H; Bowdish KS
Hum Antibodies; 2007; 16(3-4):99-105. PubMed ID: 18334745
[TBL] [Abstract][Full Text] [Related]
32. Serological studies of patients with cutaneous and oral-oropharyngeal anthrax from northern Thailand.
Sirisanthana T; Nelson KE; Ezzell JW; Abshire TG
Am J Trop Med Hyg; 1988 Dec; 39(6):575-81. PubMed ID: 3144920
[TBL] [Abstract][Full Text] [Related]
33. A two-stage, multilevel quality control system for serological assays in anthrax vaccine clinical trials.
Soroka SD; Schiffer JM; Semenova VA; Li H; Foster L; Quinn CP
Biologicals; 2010 Nov; 38(6):675-83. PubMed ID: 20875951
[TBL] [Abstract][Full Text] [Related]
34. VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area.
Nyman D; Willén L; Jansson C; Carlsson SA; Granlund H; Wahlberg P
Clin Microbiol Infect; 2006 May; 12(5):496-7. PubMed ID: 16643532
[No Abstract] [Full Text] [Related]
35. Evaluation of immune response to orally administered Sterne strain 34F2 anthrax vaccine.
Shakya KP; Hugh-Jones ME; Elzer PH
Vaccine; 2007 Jul; 25(29):5374-7. PubMed ID: 17555849
[TBL] [Abstract][Full Text] [Related]
36. Leptospirosis serodiagnosis by ELISA based on recombinant outer membrane protein.
Chalayon P; Chanket P; Boonchawalit T; Chattanadee S; Srimanote P; Kalambaheti T
Trans R Soc Trop Med Hyg; 2011 May; 105(5):289-97. PubMed ID: 21353274
[TBL] [Abstract][Full Text] [Related]
37. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
[TBL] [Abstract][Full Text] [Related]
38. Comparison of bis-di-octadecylamide of trehalose dicarboxylic acid (BDA.TDA) with glycolipid SL-IV as ELISA antigens for the serodiagnosis of leprosy.
Laszlo A; Cruaud P; Goren MB; Handzel V; Papa F; David HL
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):376-81. PubMed ID: 1282141
[TBL] [Abstract][Full Text] [Related]
39. Rapid serodiagnosis of gram-positive bacterial endocarditis.
Connaughton M; Lang S; Tebbs SE; Littler WA; Lambert PA; Elliott TS
J Infect; 2001 Feb; 42(2):140-4. PubMed ID: 11531321
[TBL] [Abstract][Full Text] [Related]
40. Serodiagnosis of borreliosis: indirect immunofluorescence assay, enzyme-linked immunosorbent assay and immunoblotting.
Wojciechowska-Koszko I; Mączyńska I; Szych Z; Giedrys-Kalemba S
Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):69-77. PubMed ID: 21258869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
